PBPH Among Health Care ETFs
End-of-day Nov 18, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.6% | −3.5% | +2.4% | +4.5% | +20.9% | — | — | — | — | +21.8% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$171 of every $1,000 in PBPH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLY.TOELI Lilly | Healthcare | 17.07% | $1,707.41 | 168K | $237.7M |
| 2 | JNJ.TOJohnson & Johnson | Healthcare | 9.62% | $961.92 | 480K | $133.9M |
| 3 | ABBVAbbvie | Healthcare | 7.41% | $740.61 | 352K | $103.1M |
| 4 | MRKMerck | Healthcare | 5.07% | $507.15 | 492K | $70.6M |
| 5 | —Roche AG | — | 4.90% | $490.02 | 141K | $68.2M |
| 6 | AZN.LAstrazeneca | Healthcare | 4.70% | $470.14 | 359K | $65.4M |
| 7 | AMGNAmgen | Healthcare | 4.34% | $434.18 | 132K | $60.4M |
| 8 | NOVN.SWNovartis Ag-reg | Healthcare | 4.14% | $413.93 | 363K | $57.6M |
| 9 | GILD.TOGilead Sciences | Healthcare | 4.13% | $412.88 | 338K | $57.5M |
| 10 | PFE.BAPfizer | Healthcare | 3.18% | $317.70 | 1.6M | $44.2M |
| 11 | VRTXVertex Pharmaceuticals | Healthcare | 2.63% | $263.34 | 69K | $36.7M |
| 12 | —Novo Nordisk A/s-b | — | 2.53% | $253.12 | 869K | $35.2M |
| 13 | BMYBristol-myers Squibb | Healthcare | 2.45% | $245.29 | 557K | $34.1M |
| 14 | SAN.PASanofi | Healthcare | 2.02% | $201.68 | 295K | $28.1M |
| 15 | REGNRegeneron Pharmaceuticals | Healthcare | 1.86% | $185.87 | 27K | $25.9M |
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 24, 2025 | Dec 26, 2025 | $0.0230 |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY.TO | ELI Lilly & | 17.07% |
| 2 | JNJ.TO | Johnson & Johnson | 9.62% |
| 3 | ABBV | Abbvie | 7.41% |
| 4 | MRK | Merck & | 5.07% |
| 5 | AZN.L | Astrazeneca | 4.70% |
| 6 | AMGN | Amgen | 4.34% |
| 7 | NOVN.SW | Novartis Ag-reg | 4.14% |
| 8 | GILD.TO | Gilead Sciences | 4.13% |
| 9 | PFE.BA | Pfizer | 3.18% |
| 10 | VRTX | Vertex Pharmaceuticals | 2.63% |